The EHMT2-AZGP1-TGF-β1 pathway suppresses NK cell-mediated cytotoxicity by downregulating NKG2D ligands on cancer cells and by modulating the regulators of cytotoxicity in NK cells. Here, TGFB1 is linked to cancer.